Study of OCV-501 in Patients With Acute Myeloid Leukemia (AML) (Extension From Study 311-10-001)
Status:
Completed
Trial end date:
2016-12-22
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety of OCV-501 in patients with AML who
completed the Study 311-10-001 and were judged that there was no relapse by any inspections
in the end of the study.